Eflornithine

ornithine decarboxylase, structural 1 ; Mus musculus







230 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 32101568 KLF4 is required for suppression of histamine synthesis by polyamines during bone marrow-derived mast cell differentiation. 2020 2
2 32911426 Targeting polyamine as a novel therapy in xenograft models of malignant pleural mesothelioma. 2020 Oct 2
3 33244237 Simultaneous Inhibition of Ornithine Decarboxylase 1 and Pyruvate Kinase M2 Exerts Synergistic Effects Against Hepatocellular Carcinoma Cells. 2020 1
4 33403098 Inhibition of ornithine decarboxylase restores hypoxic pulmonary vasoconstriction in endotoxemic mice. 2020 Oct-Dec 1
5 30700572 Inhibition of polyamine synthesis and uptake reduces tumor progression and prolongs survival in mouse models of neuroblastoma. 2019 Jan 30 2
6 30927735 α-Difluoromethylornithine suppresses inflammatory arthritis by impairing myeloid-derived suppressor cells. 2019 Jun 4
7 31088836 DFMO and 5-Azacytidine Increase M1 Macrophages in the Tumor Microenvironment of Murine Ovarian Cancer. 2019 Jul 1 2
8 29635516 Metabolomic studies identify changes in transmethylation and polyamine metabolism in a brain-specific mouse model of tuberous sclerosis complex. 2018 Jun 15 1
9 29240775 Ornithine decarboxylase as a therapeutic target for endometrial cancer. 2017 3
10 26529275 Inhibition of Polyamine Uptake Potentiates the Anti-Proliferative Effect of Polyamine Synthesis Inhibition and Preserves the Contractile Phenotype of Vascular Smooth Muscle Cells. 2016 Jun 2
11 26663722 Targeting Ornithine Decarboxylase by α-Difluoromethylornithine Inhibits Tumor Growth by Impairing Myeloid-Derived Suppressor Cells. 2016 Jan 15 6
12 27293987 Simultaneous targeting of 5-LOX-COX and ODC block NNK-induced lung adenoma progression to adenocarcinoma in A/J mice. 2016 1
13 26112945 Effect of polyamine metabolism inhibitors on Lewis lung carcinoma growth and metastasis. 2015 Jun 2
14 26426536 Ornithine Decarboxylase Activity Is Required for Prostatic Budding in the Developing Mouse Prostate. 2015 2
15 23846959 Protective effects of polyamine depletion in mouse models of type 1 diabetes: implications for therapy. 2014 Mar 1
16 24305501 Combined administration of testosterone plus an ornithine decarboxylase inhibitor as a selective prostate-sparing anabolic therapy. 2014 Apr 2
17 24778323 Polyamine-blocking therapy reverses immunosuppression in the tumor microenvironment. 2014 Mar 1
18 25248858 Eflornithine (DFMO) prevents progression of pancreatic cancer by modulating ornithine decarboxylase signaling. 2014 Dec 7
19 23300995 Critical roles of Myc-ODC axis in the cellular transformation induced by myeloproliferative neoplasm-associated JAK2 V617F mutant. 2013 4
20 24260338 Inhibiting cycloxygenase and ornithine decarboxylase by diclofenac and alpha-difluoromethylornithine blocks cutaneous SCCs by targeting Akt-ERK axis. 2013 3
21 21809076 Polyamine metabolism is involved in adipogenesis of 3T3-L1 cells. 2012 Feb 4
22 23123718 [Analysis of oncogenic signaling pathway induced by a myeloproliferative neoplasm-associated Janus kinase 2 (JAK2) V617F mutant]. 2012 2
23 23181218 Polyamine pathway inhibition as a novel therapeutic approach to treating neuroblastoma. 2012 2
24 20844550 Elevated epidermal ornithine decarboxylase activity suppresses contact hypersensitivity. 2011 Jan 2
25 21237263 LPS-induced CCL2 expression and macrophage influx into the murine central nervous system is polyamine-dependent. 2011 May 1
26 21464038 Phospho-sulindac (OXT-328) combined with difluoromethylornithine prevents colon cancer in mice. 2011 Jul 4
27 21505150 Ornithine decarboxylase is upregulated by the androgen receptor in skeletal muscle and regulates myoblast proliferation. 2011 Jul 1
28 21730362 A prolonged and exaggerated wound response with elevated ODC activity mimics early tumor development. 2011 Sep 1
29 20600019 Polyamines Impair Immunity to Helicobacter pylori by Inhibiting L-Arginine Uptake Required for Nitric Oxide Production. 2010 Nov 1
30 19001365 Spermine synthase deficiency leads to deafness and a profound sensitivity to alpha-difluoromethylornithine. 2009 Jan 9 2
31 19147568 Targeting ornithine decarboxylase impairs development of MYCN-amplified neuroblastoma. 2009 Jan 15 2
32 19427401 Identification of proteins whose synthesis is preferentially enhanced by polyamines at the level of translation in mammalian cells. 2009 Nov 1
33 20095973 Polyamines as mediators of APC-dependent intestinal carcinogenesis and cancer chemoprevention. 2009 Nov 4 4
34 18202119 Polyamines are essential in embryo implantation: expression and function of polyamine-related genes in mouse uterus during peri-implantation period. 2008 May 2
35 18381427 Elevated ornithine decarboxylase levels activate ataxia telangiectasia mutated-DNA damage signaling in normal keratinocytes. 2008 Apr 1 1
36 18583422 Molecular and morphological changes in placenta and embryo development associated with the inhibition of polyamine synthesis during midpregnancy in mice. 2008 Oct 2
37 19047152 ODC1 is a critical determinant of MYCN oncogenesis and a therapeutic target in neuroblastoma. 2008 Dec 1 2
38 17148758 Sexual dimorphism of ornithine decarboxylase in the mouse adrenal: influence of polyamine deprivation on catecholamine and corticoid levels. 2007 Apr 1
39 17675337 Studies of the mechanism by which increased spermidine/spermine N1-acetyltransferase activity increases susceptibility to skin carcinogenesis. 2007 Nov 1
40 16678846 Involvement of polyamines in apoptosis of cardiac myoblasts in a model of simulated ischemia. 2006 Jun 2
41 15514084 Influence of ovarian ornithine decarboxylase in folliculogenesis and luteinization. 2005 Feb 2
42 15611981 Polyamines modulate carcinogen-induced mutagenesis in vivo. 2005 2
43 15695401 Induction of ornithine decarboxylase activity is a necessary step for mitogen-activated protein kinase kinase-induced skin tumorigenesis. 2005 Jan 15 2
44 15894264 Targeting ornithine decarboxylase in Myc-induced lymphomagenesis prevents tumor formation. 2005 May 3
45 16138831 Polyamines are involved in murine kidney development controlling expression of c-ret, E-cadherin, and Pax2/8 genes. 2005 Jul 1
46 15067319 Ornithine decarboxylase is a target for chemoprevention of basal and squamous cell carcinomas in Ptch1+/- mice. 2004 Mar 1
47 15175104 Therapy of murine squamous cell carcinomas with 2-difluoromethylornithine. 2004 Jun 2 3
48 15265947 Protective role of arginase in a mouse model of colitis. 2004 Aug 1 1
49 12771040 Celecoxib and difluoromethylornithine in combination have strong therapeutic activity against UV-induced skin tumors in mice. 2003 May 3
50 12856719 Effects of alpha-difluoromethylornithine on local recurrence and pulmonary metastasis from MDA-MB-435 breast cancer xenografts in nude mice. 2003 4